These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1624 related articles for article (PubMed ID: 15536203)
21. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells. Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736 [TBL] [Abstract][Full Text] [Related]
23. Regulation of growth hormone receptors in human prostate cancer cell lines. Bidosee M; Karry R; Weiss-Messer E; Barkey RJ Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305 [TBL] [Abstract][Full Text] [Related]
24. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366 [TBL] [Abstract][Full Text] [Related]
25. Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes. Hartel A; Didier A; Ulbrich SE; Wierer M; Meyer HH J Steroid Biochem Mol Biol; 2004 Oct; 92(3):187-97. PubMed ID: 15555912 [TBL] [Abstract][Full Text] [Related]
26. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells. Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877 [TBL] [Abstract][Full Text] [Related]
27. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP. Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640 [TBL] [Abstract][Full Text] [Related]
28. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
29. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937 [TBL] [Abstract][Full Text] [Related]
30. The IGF system in the neonatal ovine uterus. Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960 [TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [TBL] [Abstract][Full Text] [Related]
32. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
33. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705 [TBL] [Abstract][Full Text] [Related]
34. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911 [TBL] [Abstract][Full Text] [Related]
35. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Miyake H; Pollak M; Gleave ME Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457 [TBL] [Abstract][Full Text] [Related]
36. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Evangelou A; Jindal SK; Brown TJ; Letarte M Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107 [TBL] [Abstract][Full Text] [Related]
39. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer. Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231 [TBL] [Abstract][Full Text] [Related]
40. Hormone regulation of human prostate in organ culture. Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]